logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Maastricht UMC+

+31433876543
poli.oncologie@mumc.nl
Source: Site record.
http://www.mumc.nl

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Maastricht UMC+ is a prominent academic medical centre in the Netherlands known for its integrated approach to health recovery, preservation, and promotion. Formed through a partnership between the academic hospital Maastricht (azM) and the Faculty of Health, Medicine and Life Sciences of Maastricht University, it serves as a critical healthcare provider for the southeastern region of the country.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
62Total Trials
Source: Trial-derived.
18Recruiting Trials
Source: Trial-derived.
22Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
104Unique Conditions
Source: Trial-derived.
95Unique Sponsors

Conditions

Source: Trial-derived. Breast Neoplasms (3)Source: Trial-derived. Protein Metabolism (3)Source: Trial-derived. HELLP Syndrome (2)Source: Trial-derived. Intrauterine Growth Restriction (2)Source: Trial-derived. Non-small Cell Lung Cancer (2)Source: Trial-derived. Pre-Eclampsia (2)Source: Trial-derived. Pregnancy (2)Source: Trial-derived. Acute Knee Cartilage Injury (1)

Sponsors

Source: Trial-derived. Maastricht University Medical Center (24)Source: Trial-derived. Academisch Ziekenhuis Maastricht (4)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Erasmus Medical Center (3)Source: Trial-derived. Hoffmann-La Roche (3)Source: Trial-derived. Radboud University Medical Center (3)Source: Trial-derived. Universitaire Ziekenhuizen KU Leuven (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Radiographic tumour response assessment